After Celgene Deal Juno Revs Armored CAR For Ovarian Cancer Trial
July 10, 2015 | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells. Xconomy
CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our Privacy Policy for more information.
July 10, 2015 | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells. Xconomy